期刊文献+

桃红四物汤合五苓散加减联合氢氯噻嗪治疗慢性肾衰竭血瘀水湿证的临床研究 被引量:4

Clinical Study of modified Taohong Siwu Decoction and Wuling Powder combined with hydrochlorothiazide in treating chronic renal failure with blood stasis and water damp syndrome
下载PDF
导出
摘要 目的 探讨桃红四物汤合五苓散加减联合氢氯噻嗪治疗慢性肾衰竭(CRF)血瘀水湿证的临床疗效。方法 选择首都医科大学附属北京中医医院及北京市平谷区中医医院肾病科门诊2018年4月—2020年5月收治的CRF血瘀水湿证患者60例,按照随机数字表法分为观察组和对照组各30例。对照组给予常规治疗+口服氢氯噻嗪片,观察组在对照组基础上联合桃红四物汤合五苓散加减治疗,疗程2个月。所有受试者治疗前后进行中医证候积分、36项健康调查简表(SF-36)及急性生理和慢性健康状况评分Ⅱ(APACHEⅡ)评分,并检测肾功能指标血清肌酐(Cr)、尿素氮(BUN)水平及24 h尿蛋白定量(24 h-UTP),以及血清炎症指标,包括白介素-6 (IL-6)、肿瘤坏死因子-α (TNF-α)、C反应蛋白(CRP)浓度,统计不良反应发生情况。结果 观察组总有效率为90.0%,对照组为60.0%,2组比较差异有统计学意义(P<0.01)。与治疗前比较,治疗后2组中医证候积分均降低(P<0.01),观察组低于对照组(P<0.01)。与治疗前比较,治疗后2组血清Cr、BUN、IL-6、TNF-α、CRP及24 h-UTP均降低(P<0.01),观察组指标低于对照组(P<0.01)。与治疗前比较,治疗后2组SF-36评分均升高(P<0.05),APACHEⅡ评分均降低(P<0.01);与对照组比较,治疗后观察组SF-36评分升高,APACHEⅡ评分降低(P<0.01)。2组不良反应均较少且轻微。结论 桃红四物汤合五苓散加减联合氢氯噻嗪治疗CRF血瘀水湿证能显著下调患者血清相关炎症因子的表达水平,改善肾功能,安全且有效。 Objective To explore the clinical effect of modified Taohong Siwu Decoction and Wuling Powder combined with hydrochlorothiazide on chronic renal failure(CRF) with blood stasis and water damp syndrome. Methods 60 CRF patients with blood stasis and water dampness syndrome received by Department of Nephrology of Beijing Hospital of Traditional Chinese Medicine Affiliated to the Capital Medical University and Beijing Pinggu District Hospital of Traditional Chinese Medicine from April 2018 to May 2020 were selected and divided into observation group(n=30) and control group(n=30). All patients were given the same routine treatment plus orally taking hydrochlorothiazide,and on the basis of treatment in observation group, the control group also combined modified Taohong Siwu Tang plus Wuling Powder treatment, with the treatment course of 2 months. Before and after treatment,TCM syndrome score, 36 Health Survey Synopsis(SF-36), acute physiological and chronic health condition score II(Apache II), renal function index including serum creatinine(CR), urea nitrogen(Bun) level and 24h-UTP,inflammatory index including serum interleukin-6(IL-6),tumor necrosis factor factor(TNF-α), c-reactive protein(CRP)concentration were measured. Results The total effective rate of the observation group was 90.00%(27/30), which was significantly higher than that of the control group(60.00%, 18/30)(P<0.01). Compared with that before treatment, TCM syndrome scores of both two groups were decreased after treatment(P<0.01), and the observation group was lower than the control group(P<0.01). The levels of CR, Bun, IL-6, TNF-α, CRP and 24h-UTP in the two groups after treatment were significantly lower than those before treatment(P<0.05), but the levels of above index in the observation group were significantly lower than those in the control Group(P<0.01). Compared with that of the control group,SF-36 scores were significantly increased(P<0.01) and Apache II scores were significantly decreased(P<0.01) in both groups after treatment, and SF-36 scores were significantly higher(P<0.01) and Apache II scores were significantly lower(P<0.01) in the observation group than in the control group. The side effects were few and mild in both groups. Conclusion Modified Taohong Siwu Decoction and Wuling Powder combined with hydrochlorothiazide can effectively and safely decrease the expression of serum inflammatory factors in CRF patients with blood stasis and dampness syndrome,and improve their renal function.
作者 杨俊 赵春芝 张磊 关晓杰 郑桂敏 蔡朕 赵凯声 赵文景 YANG Jun;ZHAO Chun-zhi;ZHANG Lei;GUAN Xiao-jie;ZHENG Gui-min;CAI Zhen;ZHAO Kai-sheng;ZHAO Wen-jing(Department of Nephrology,Beijing Pinggu District Hospital of Traditional Chinese Medicine,Beijing 101200,China;Department of Nephrology,Beijing Hospital of Traditional Chinese Medicine Affiliated to the Capital Medical University,Beijing 100010)
出处 《北京中医药》 2022年第11期1305-1309,共5页 Beijing Journal of Traditional Chinese Medicine
基金 首都卫生发展科研专项(首发2019-4024-05)。
关键词 桃红四物汤 五苓散 氢氯噻嗪 慢性肾衰竭 血瘀水湿证 Taohong Siwu Decoction Wuling Powder hydrochlorothiazide chronic kidney failure blood stasis and dampness syndrome
  • 相关文献

参考文献10

二级参考文献131

共引文献2526

同被引文献75

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部